TGFBR1 and pulmonary fibrosis: In vascular and pulmonary fibrosis, let-7i-5p inhibits endothelial to mesenchymal transition (EndoMT) or fibroblast activation by targeting Tgfbr1 (Chen et al., 2020; Xu et al., 2022).